Sophia Lengsfeld
Basel, BS 4001, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Blood pressure changes during smoking cessation in a randomized, double-blind, placebo-controlled trial of dulaglutide treatment.
Journal: European journal of preventive cardiology
Published: October 23, 2024
Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study.
Journal: EBioMedicine
Published: January 26, 2024
Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial.
Journal: EClinicalMedicine
Published: October 30, 2023
Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: a predefined secondary analysis of a randomised trial.
Journal: BMJ nutrition, prevention & health
Published: September 15, 2023
Effects of dulaglutide on alcohol consumption during smoking cessation.
Journal: JCI insight
Published: March 28, 2023
Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial.
Journal: EClinicalMedicine
Published: October 26, 2022
Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled study.
Journal: Trials
Published: January 30, 2022
Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis.
Journal: Journal of internal medicine
Published: August 03, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026